← Leaderboards
Theo C Manschreck
Harvard Medical School
$991,724
Attributed
$991,724
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $211.2K · FY2006–10$250K$187.5K$125K$62.5K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$991,724 · 1
By mechanism
U01$991,724 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Haiden A. Huskamp$16,539,345
- Carole D Mitnick$5,268,466
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationMasksAccident And Emergency DepartmentAdherence (Attribute)Adverse EffectsBlindAntipsychotic AgentsClinical ResearchAtypical AntipsychoticConsentCountryBed OccupancyDay CareDesignDiscontinuation TrialCholesterolEffectivenessEffectiveness TrialGenerationsGlucoseHealth BenefitHospitalsInjectableMetabolic
Grant awards (5)
Relapse Prevention: Long Acting Atypical Antipsychotics$207,267
U01 · FY2010 · MH · contact PI
Relapse Prevention: Long Acting Atypical Antipsychotics$186,940
U01 · FY2009 · MH · contact PI
Relapse Prevention: Long Acting Atypical Antipsychotics$192,832
U01 · FY2008 · MH · contact PI
Relapse Prevention: Long Acting Atypical Antipsychotics$193,527
U01 · FY2007 · MH · contact PI
Relapse Prevention: Long Acting Atypical Antipsychotics$211,158
U01 · FY2006 · MH · contact PI